News for Delcath Systems, Inc. (DCTH)

Delcath Systems (DCTH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Delcath Systems, Inc. (Nasdaq: DCTH) (”œDelcath” or the ”œCompany”), an interventional oncology company focused on the treatment of primary and metastati

Transaction Overview On December 31, 2024, Rosalind Advisors, Inc. (Trades, Portfolio) made a strategic move by acquiring an additional 9,536,647 shares in Biof

Does Delcath Systems, Inc. (DCTH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Shares of Delcath Systems Inc. (DCTH) touched a new 52-week high of $16.97 last week, and that reflects a gain of over 100% in less than 6 months..

On December 31, 2024, Rosalind Advisors, Inc. (Trades, Portfolio) made a significant move by adding 412,087 shares of OptiNose Inc. (NASDAQ: OPTN) to its portfo

On December 31, 2024, Rosalind Advisors, Inc. (Trades, Portfolio) significantly increased its investment in InspireMD Inc. by acquiring an additional 7,419,918

The average of price targets set by Wall Street analysts indicates a potential upside of 33.7% in Delcath Systems (DCTH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Delcath Systems (DCTH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Shares of Delcath Systems Inc (DCTH) surged 6.45% in mid-day trading on Jan 16. The stock reached an intraday high of $13.55, before settling at $13.53, up

We recently compiled a list of the 14 Best 52-Week High Stocks To Buy According to Analysts. In this article, we are going to take a look at where Delcath Systems, Inc.

Delcath Systems (DCTH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Delcath Systems, Inc. (Nasdaq: DCTH) (the ”œCompany” or ”œDelcath”), an interventional oncology company focused on the treatment of primary and metastati

Shares of Delcath Systems Inc (DCTH) fell 3.72% in mid-day trading on Dec 27. The stock reached an intraday low of $11.42, before recovering slightly to $11.5

U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Thursday.

Shares of Zoomcar Holdings, Inc. ZCAR rose sharply in today's pre-market trading after it reported a 43% year-on-year growth in bookings for November 2024, prim...

Shares of Delcath Systems Inc (DCTH) fell 5.46% in mid-day trading on Dec 3. The stock reached an intraday low of $11.68, before recovering slightly to $11.95

On November 12, 2024, Rosalind Advisors, Inc. (Trades, Portfolio) made a strategic move by acquiring 2,100,840 shares of Neuraxis Inc (NRXS). This transaction,

Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that